Is there a difference between ruxolitinib cream and ruxolitinib?

Although Ruxolitinib cream (Opzelura) and Ruxolitinib (Ruxolitinib) have the same ingredients and are both JAK1/2 inhibitors, they have obvious differences in dosage forms, indications and clinical uses. Ruxolitinib cream is a topical preparation, while ruxolitinib is an oral medication. Although the pharmacological mechanism of both drugs is the same, both regulate the immune response and inflammatory response by inhibiting the JAK-STAT signaling pathway, their respective usage methods determine their different clinical applicability.

Ruxolitinib cream is mainly used to treat non-segmental vitiligo and mild to moderate atopic dermatitis. It is the first JAK inhibitor external drug approved for the treatment of vitiligo. Through topical application, it can directly act on inflammatory cells on the skin surface, reduce damage to melanocytes, and promote pigment recovery. Its advantages include strong targeting and relatively few side effects, making it suitable for patients with skin diseases that require topical treatment.

In contrast, ruxolitinib oral tablets are used to treat systemic diseases such as moderate-to-high-risk polycythemia vera, myelofibrosis, and rheumatoid arthritis. Such diseases usually require systemic inhibition of the abnormally active JAK signaling pathway, thus requiring systemic medication. Ruxolitinib can effectively relieve symptoms and delay disease progression in this type of disease, but because it is a systemic treatment, it may also cause more systemic side effects, such as anemia and increased risk of infection.

To sum up, ruxolitinib cream and ruxolitinib are essentially the same molecule as drugs, but due to different dosage forms, one is used as a topical drug for skin diseases, and the other is used as a systemic treatment for blood system or immune system diseases, and the clinical application scenarios are quite different. Patients should choose the most appropriate dosage form and treatment plan according to the doctor's advice and avoid using it by themselves.

Reference materials:https://www.opzelura.com/